BREZTRI 160 ug/1

BREZTRI 160 µg/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is used for respiratory conditions like asthma and COPD. This metered aerosol provides targeted relief for breathing difficulties.

BREZTRI 160 µg/1 is primarily used for the maintenance treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The combination of budesonide, glycopyrrolate, and formoterol fumarate works to reduce inflammation and relax the airways, making it easier to breathe. This inhaler is often prescribed for individuals who require a combination of medications to manage their symptoms effectively. What is BREZTRI used for? It is designed to help control and prevent symptoms associated with chronic respiratory conditions.

Common effects of using BREZTRI 160 µg/1 may include improved breathing and reduced wheezing. Some users might experience side effects such as throat irritation, dry mouth, or headaches. These effects can vary from person to person, and it is important to consult a healthcare provider if any adverse reactions are severe or persistent.

When using BREZTRI 160 µg/1, it is important to follow the prescribed dosage and administration instructions carefully. Always use the inhaler as directed by your healthcare provider. Keep the inhaler clean and store it properly to maintain its effectiveness. Avoid exposure to extreme temperatures and humidity, as these can affect the medication's stability.

BREZTRI 160 µg/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, avoid using alcohol or other substances that may affect your respiratory system while using this inhaler.